1. Home
  2. SER vs MAGH Comparison

SER vs MAGH Comparison

Compare SER & MAGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • MAGH
  • Stock Information
  • Founded
  • SER 2017
  • MAGH 2012
  • Country
  • SER United States
  • MAGH Singapore
  • Employees
  • SER N/A
  • MAGH N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • MAGH Engineering & Construction
  • Sector
  • SER Health Care
  • MAGH Industrials
  • Exchange
  • SER Nasdaq
  • MAGH Nasdaq
  • Market Cap
  • SER 56.5M
  • MAGH 51.8M
  • IPO Year
  • SER 2018
  • MAGH 2025
  • Fundamental
  • Price
  • SER $5.11
  • MAGH $1.04
  • Analyst Decision
  • SER Strong Buy
  • MAGH
  • Analyst Count
  • SER 2
  • MAGH 0
  • Target Price
  • SER $13.00
  • MAGH N/A
  • AVG Volume (30 Days)
  • SER 326.5K
  • MAGH 678.9K
  • Earning Date
  • SER 08-11-2025
  • MAGH 01-01-0001
  • Dividend Yield
  • SER N/A
  • MAGH N/A
  • EPS Growth
  • SER N/A
  • MAGH N/A
  • EPS
  • SER N/A
  • MAGH 0.03
  • Revenue
  • SER $130,000.00
  • MAGH $13,529,576.00
  • Revenue This Year
  • SER N/A
  • MAGH N/A
  • Revenue Next Year
  • SER N/A
  • MAGH N/A
  • P/E Ratio
  • SER N/A
  • MAGH $35.69
  • Revenue Growth
  • SER N/A
  • MAGH 10.71
  • 52 Week Low
  • SER $3.81
  • MAGH $0.99
  • 52 Week High
  • SER $10.28
  • MAGH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • SER 44.13
  • MAGH N/A
  • Support Level
  • SER $5.00
  • MAGH N/A
  • Resistance Level
  • SER $5.49
  • MAGH N/A
  • Average True Range (ATR)
  • SER 0.53
  • MAGH 0.00
  • MACD
  • SER -0.01
  • MAGH 0.00
  • Stochastic Oscillator
  • SER 12.36
  • MAGH 0.00

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About MAGH Magnitude International Ltd Ordinary Shares

Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.

Share on Social Networks: